204 related articles for article (PubMed ID: 1833245)
1. Medical treatment of endometriosis: a comparison of the suppressive effects of danazol and nafarelin on reproductive hormones.
Hickok LR; Burry KA; Cohen NL; Moore DE; Dahl KD; Soules MR
Fertil Steril; 1991 Oct; 56(4):622-7. PubMed ID: 1833245
[TBL] [Abstract][Full Text] [Related]
2. A comparative treatment trial of endometriosis using the gonadotrophin-releasing hormone agonist, nafarelin, and the synthetic steroid, danazol.
Fraser IS; Shearman RP; Jansen RP; Sutherland PD
Aust N Z J Obstet Gynaecol; 1991 May; 31(2):158-63. PubMed ID: 1834049
[TBL] [Abstract][Full Text] [Related]
3. Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial.
Henzl MR; Corson SL; Moghissi K; Buttram VC; Berqvist C; Jacobson J
N Engl J Med; 1988 Feb; 318(8):485-9. PubMed ID: 2963213
[TBL] [Abstract][Full Text] [Related]
4. On the origin and significance of serum CA-125 concentrations in 97 patients with endometriosis before, during, and after buserelin acetate, nafarelin, or danazol.
Franssen AM; van der Heijden PF; Thomas CM; Doesburg WH; Willemsen WN; Rolland R
Fertil Steril; 1992 May; 57(5):974-9. PubMed ID: 1533376
[TBL] [Abstract][Full Text] [Related]
5. The hypothalamic-pituitary-ovarian axis in patients with endometriosis is suppressed by leuprolide acetate but not by danazol.
Sakata M; Ohtsuka S; Kurachi H; Miyake A; Terakawa N; Tanizawa O
Fertil Steril; 1994 Mar; 61(3):432-7. PubMed ID: 8137962
[TBL] [Abstract][Full Text] [Related]
6. A randomized, prospective comparison of endocrine changes induced with intranasal leuprolide or danazol for treatment of endometriosis.
Tummon IS; Pepping ME; Binor Z; Radwanska E; Dmowski WP
Fertil Steril; 1989 Mar; 51(3):390-4. PubMed ID: 2522062
[TBL] [Abstract][Full Text] [Related]
7. Nafarelin for endometriosis: a large-scale, danazol-controlled trial of efficacy and safety, with 1-year follow-up. The Nafarelin European Endometriosis Trial Group (NEET).
Fertil Steril; 1992 Mar; 57(3):514-22. PubMed ID: 1531464
[TBL] [Abstract][Full Text] [Related]
8. Treatment of endometriosis with a potent agonist of gonadotropin-releasing hormone (nafarelin).
Schriock E; Monroe SE; Henzl M; Jaffe RB
Fertil Steril; 1985 Nov; 44(5):583-8. PubMed ID: 2932349
[TBL] [Abstract][Full Text] [Related]
9. Effects of nafarelin versus danazol on lipids and calcium metabolism.
Bergquist C
Am J Obstet Gynecol; 1990 Feb; 162(2):589-91. PubMed ID: 2137977
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of nafarelin in the treatment of endometriosis.
Henzl MR; Kwei L
Am J Obstet Gynecol; 1990 Feb; 162(2):570-4. PubMed ID: 2137971
[TBL] [Abstract][Full Text] [Related]
11. Nafarelin versus danazol in the treatment of endometriosis.
Rolland R; van der Heijden PF
Am J Obstet Gynecol; 1990 Feb; 162(2):586-8. PubMed ID: 2137976
[TBL] [Abstract][Full Text] [Related]
12. Metabolic changes during medical treatment of endometriosis: nafarelin acetate versus danazol.
Burry KA; Patton PE; Illingworth DR
Am J Obstet Gynecol; 1989 Jun; 160(6):1454-9; discussion 1459-61. PubMed ID: 2525337
[TBL] [Abstract][Full Text] [Related]
13. Comparison between the effects of nafarelin and danazol on serum lipids and lipoproteins in patients with endometriosis.
Välimäki M; Nilsson CG; Roine R; Ylikorkala O
J Clin Endocrinol Metab; 1989 Dec; 69(6):1097-103. PubMed ID: 2531153
[TBL] [Abstract][Full Text] [Related]
14. The effects of nafarelin and danazol on vertebral trabecular bone mass in patients with endometriosis.
Whitehouse RW; Adams JE; Bancroft K; Vaughan-Williams CA; Elstein M
Clin Endocrinol (Oxf); 1990 Sep; 33(3):365-73. PubMed ID: 2147597
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic management of endometriosis.
Saltiel E; Garabedian-Ruffalo SM
Clin Pharm; 1991 Jul; 10(7):518-31. PubMed ID: 1830521
[TBL] [Abstract][Full Text] [Related]
16. A comparison of nafarelin acetate and danazol in the treatment of endometriosis.
Kennedy SH; Williams IA; Brodribb J; Barlow DH; Shaw RW
Fertil Steril; 1990 Jun; 53(6):998-1003. PubMed ID: 2140996
[TBL] [Abstract][Full Text] [Related]
17. LRF and TRF test during long-term danazol treatment: increase of the LH and FSH responses but decrease of the prolactin and TSH responses.
Leppäluoto J; Rönnberg L; Ylöstalo P
Acta Endocrinol (Copenh); 1983 Sep; 104(1):1-5. PubMed ID: 6414205
[TBL] [Abstract][Full Text] [Related]
18. Nafarelin: a new medical therapy for endometriosis.
Henzl MR; Monroe SE
Prog Clin Biol Res; 1990; 323():343-55. PubMed ID: 2137620
[No Abstract] [Full Text] [Related]
19. Nafarelin acetate: a gonadotropin-releasing hormone agonist for the treatment of endometriosis.
Letassy NA; Thompson DF; Britton ML; Suda RR
DICP; 1990 Dec; 24(12):1204-9. PubMed ID: 2151003
[TBL] [Abstract][Full Text] [Related]
20. The rapid ovarian secretory response to pituitary stimulation by the gonadotropin-releasing hormone agonist nafarelin in sexual precocity.
Rosenfield RL; Garibaldi LR; Moll GW; Watson AC; Burstein S
J Clin Endocrinol Metab; 1986 Dec; 63(6):1386-9. PubMed ID: 2946712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
